Dr. Webster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
401 North Broadway Street
Weinberg BLDG
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-367-2194
Education & Training
Johns Hopkins UniversityFellowship, Medical Oncology, 2017- Johns Hopkins UniversityResidency, Internal Medicine, 2011 - 2013
Stanford University School of MedicineClass of 2011
Certifications & Licensure
VA State Medical License 2021 - 2026
MD State Medical License 2014 - 2025
PA State Medical License 2024 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance Start of enrollment: 2017 Sep 05
Roles: Contact, Principal Investigator
- Post-transplant Flotetuzumab for AML Start of enrollment: 2022 Oct 20
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results ...Neil D Palmisiano, Ju-Whei Lee, David F Claxton, Elisabeth M Paietta, Hassan Alkhateeb
Ejhaem. 2024-10-01 - 1 citationsImpact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplan...Sabine Kayser, Chiara Sartor, Fabio Giglio, Alessandro Bruno, Jonathan Webster
Haematologica. 2024-05-01 - 2 citationsAMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death.Jia Jia, Wenbo Ji, Antoine N Saliba, Clifford M Csizmar, Kaiqin Ye
Cell Death and Differentiation. 2024-04-01
Abstracts/Posters
- Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AMLJonathan Webster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume LeukapheresisJonathan Webster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF RegistryJune 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
